PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26026F0019PHARM - prolastin-c — Grifols Usa, LLC

Grifols Usa, LLC holds $1.7M across 29 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 2 related awards under parent 36F79722D0090. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

260-Network Contract Office 20 (36C260)

Awarding office

Grifols Usa, LLC

Recipient

Sep 30, 2026

PoP end

$111K

Obligated

$111K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Grifols Usa, LLC — $90

Contract facts

Federal

Contract number36C26026F0019

Also listed as36C260-26-F-0019

Also listed as36F79722D0090-36C26026F0019

Agency260-Network Contract Office 20 (36C260)

Awarding office260-Network Contract Office 20 (36C260)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentGrifols Usa, LLC

CAGE1N5P5

UEID48FNWJCJ5H5

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79722D0090

Place of performanceLAKE MARY FL

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startOct 1, 2025

PoP end (current)Sep 30, 2026

Obligated$111K

Current value$111K

Potential value$111K

PHARM - PROLASTIN-C is a federal award for 260-Network Contract Office 20 (36C260) held by Grifols Usa, LLC. Estimated value $111K ($111K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: LAKE MARY FL.

Recompete timing

Public

● Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Grifols Usa, LLC — $1.7M obligated across 29 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($1.7M) · all agencies

Department of Veterans Affairs (VA)$1.7M · 100%Department of Health and Human Services (HHS)$62K · 4%

Open full company profile →

Related awards

Same parent · incumbent

36C26026F0037

PROLASTIN-C LIQUID,HUMAN 1000MG/VIL.

$364K

Sep 30, 2026

36C26026F0015

PHARM - PROLASTIN-C

$120K

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26026F0019?

36C26026F0019 (PHARM - prolastin-c) is a 260-Network Contract Office 20 (36C260) award with a potential value of $111K, currently held by Grifols Usa, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C260-26-F-0019?

36C260-26-F-0019 is the dashed form of PIID 36C26026F0019 (PHARM - prolastin-c), held by Grifols Usa, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26026F0019?

260-Network Contract Office 20 (36C260) awarded 36C26026F0019 to Grifols Usa, LLC (potential $111K).

Who is the incumbent on 36C26026F0019?

Grifols Usa, LLC is the incumbent with $1.7M across 29 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Grifols Usa, LLC’s 36C26026F0019 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Oct 1, 2025